Elite Pharmaceuticals Inc
ELTP· OTC
Released Aug 15, 2022, after the close
10-Q filed Aug 15, 2022, 46 days after period end · 0001493152-22-022928
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $7.67M | $7.06M | $7.54M | $3.36M |
| Net Income | $305.88K | $2.39M | $1.08M | $279.70K |
| EPS Diluted |
Elite Pharmaceuticals Inc · CIK 1053369 · Engraved from SEC EDGAR
| $0.00 |
| $0.00 |
| $0.00 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.